Report
WHO target product profile for Bundibugyo virus disease vaccines
Bundibugyo virus (BDBV) (species Orthoebolavirus bundibugyoense), first identified in Uganda in 2007, is a distinct species in the genus Orthoebolavirus within the filovirus family; it has documented human pathogenicity and mortality. Although less frequently documented than Ebola virus (EBOV) (species Orthoebolavirus zairense), BDBV has previously caused outbreaks. On 17 May 2026, the World Health Organization (WHO) declared that the outbreak of Bundibugyo virus disease (BVD) in the Democratic Republic of the Congo and Uganda constitutes a Public Health Emergency of International Concern (1). WHO underscores the need to develop BDBV-specific vaccines (2). Dedicated vaccine development for this species is essential both for the current BVD epidemic and as a rapidly deployable preventive tool to control future BVD outbreaks.
Authors
Languages
- English
Publication year
2026
Type
Report
Categories
- Programme management
ebola-BDBV
This resource appears in the following Hot Topic page:
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026 | World Health Organization (WHO) | 2026 | Guidance | English |
| Frequently asked questions (FAQs) on Bundibugyo Virus Disease vaccines and therapeutics | World Health Organization (WHO), WHO Regional Office for Africa (AFRO) | 2026 | Datasheet | English, French |
| WHO Technical Advisory Group on Candidate Vaccine Prioritization Meeting report, 19 and 25 May 2026 | World Health Organization (WHO) | 2026 | Report | English |
| GNN webinar: Updates on existing and pipeline Ebola vaccines | Helen Rees, Reena Doshi, Alejandro Costa, Melanie Marti, Pierre Gsell | 2026 | Webinar | English |
| WHO target product profile for Bundibugyo virus disease vaccines | World Health Organization (WHO) | 2026 | Report | English |
| WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for BVD candidate vaccine prioritization (TAG-CVP) meeting report, 31 July 2026 | World Health Organization (WHO) | 2026 | Report | English |
